We have located links that may give you full text access.
CLINICAL TRIAL
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Alterations of F wave parameters after exercise in symptomatic lumbar spinal stenosis.
OBJECTIVES: The purpose of the study is to investigate changes in F wave parameters after exercise in subjects with symptomatic lumbar spinal stenosis.
DESIGN: A total of 19 older patients with lumbar spinal stenosis and neurogenic claudication participated in this cohort study. No one withdrew for adverse effects. All subjects underwent physical therapy, with half performing additional interval-walking exercises. Groups were treated for eight sessions, returning for follow-up at weeks 4 and 8. Changes in F wave indices--minimal latency, chronodispersion, and persistence--were calculated. The treatment group demonstrated worsening of F wave persistence at 8-wk follow-up (P < 0.01).
CONCLUSIONS: F wave indices worsened after an interval-walking exercise program. Subjects in the treatment group demonstrated worsening of F wave persistence at 8-wk follow-up.
DESIGN: A total of 19 older patients with lumbar spinal stenosis and neurogenic claudication participated in this cohort study. No one withdrew for adverse effects. All subjects underwent physical therapy, with half performing additional interval-walking exercises. Groups were treated for eight sessions, returning for follow-up at weeks 4 and 8. Changes in F wave indices--minimal latency, chronodispersion, and persistence--were calculated. The treatment group demonstrated worsening of F wave persistence at 8-wk follow-up (P < 0.01).
CONCLUSIONS: F wave indices worsened after an interval-walking exercise program. Subjects in the treatment group demonstrated worsening of F wave persistence at 8-wk follow-up.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app